L-Dopa and the treatment of extrapyramidal disease.
D000277:Adjuvants, Pharmaceutic; D000818:Animals; D001480:Basal Ganglia Diseases / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D001673:Biodegradation, Environmental; D002395:Catecholamines / Q000096:biosynthesis / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D010300:Parkinson Disease / Q000188:drug therapy; D051381:Rats
D000277:Adjuvants, Pharmaceutic; D002395:Catecholamines; D007980:Levodopa; D004298:Dopamine